2m 2m 2m 2m 2m 2m 2m
ATEA PHARMA (AVIR)
NASDAQ
$4.21$0.00 (0.00%)
Price as of Jun 03, 2026 4:10 PM EDT- $373.7MMarket Cap
- 32.61%1-Year Change
- BiotechnologyIndustry
ATEA PHARMA (AVIR)
$4.21$0.00 (0.00%)
AVIR | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.21 | ||
Change | -$0.11 (-2.51%) | ||
Open | $4.25 | ||
High | $4.31 | ||
Low | $4.16 | ||
Previous Close | $4.27 | ||
Volume | 330,211 | ||
30-Day Average Volume | 361,832 | ||
1-Week Change | -5.74% | ||
1-Month Change | -23.48% | ||
1-Year Change | 32.61% | ||
3-Year Change | -5.11% | ||
5-Year Change | -79.24% | ||
Fundamentals | |||
Shares Outstanding | 80.0M | ||
Total Assets | $267.1M | ||
Market Cap | $373.7M | ||
Enterprise Value | $294.4M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$45.4M | ||
Free Cash Flow | -$46.4M | ||
EBIT | -$45.4M | ||
EBITDA | -$45.3M | ||
Net Working Capital | $229.8M | ||
EPS | -$0.57 | ||
Enterprise Value/EBITDA | -7 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -8 | ||
PEG | -11 | ||
Price/Free Cash Flow | -8 | ||
Price/Operating Cash Flow | -8 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 11 | ||
Last Split Date | 02/14/2018 | ||
Earnings & Revenue